Sudarshan Pharma Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2026 ,inter alia, to consider and approve the Unaudited Standalone ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sudarshan Pharma Industries has informed BSE that its Board of Directors will meet on Wednesday, 28 January 2026 to consider and approve the unaudited standalone and consolidated financial results for the quarter ended 31 December 2025 (Q3 FY26). The company has also notified that the trading window for insiders will remain closed until 48 hours after the results are declared. This is a routine regulatory intimation under SEBI LODR Regulation 29 and contains no actual financial figures at this stage.
This is a standard pre-results announcement and typically has no direct impact on the stock. Investors should watch the actual Q3 numbers on 28 January for revenue, profit, and margin trends, which could move the stock post-announcement.